Interleukin Genetics Launches Enhanced Online Weight Loss Services For Its Inherent Health® Genetic Test

WALTHAM, Mass., May 9, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the launch of a comprehensive suite of new free and subscriber-based weight loss web-based tools on the Inherent Health website (www.inherenthealth.com). The new tools help to optimize diet and exercise management for users of the Inherent Health® Weight Management Genetic Test. These tools provide customers with a convenient, informative and fun way to manage diet and exercise based on their specific genetic makeup.

As part of the new tools, the free Inherent Diet and Nutrient Analyzer™ service includes an improved calorie and nutrient tracking tool. Now for the first time, customers will be able to record calories consumed for more than 35,000 different foods and energy burned for approximately 10,000 exercises. The Analyzer library can determine a food's macronutrient content in terms of fat, carbohydrates and protein. In addition, the application matches a person's genetics to specific menus, provides recipes for low-fat, low-carb or balanced meals. Customers on the site will also be able to create grocery lists and interact with people of similar genetic diet IDs via chat rooms. While some of the features are only available through a premium service package billed monthly, for the first 30 days after purchasing a test, customers can enjoy the full suite of all weight loss web applications for free.

"These new and improved tools are expected to improve the genetic test service and overall weight management experience of our customers," said Lewis H. Bender, CEO, Interleukin Genetics. "We're thrilled to be able to provide a comprehensive online element to our Weight Management genetic test program that will help our customers navigate their weight loss journey more effectively."

About Interleukin Genetics

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics' flagship products include its proprietary PST® genetic risk panel for periodontal disease and tooth loss susceptibility sold through dentists, and the Inherent Health Weight Management Genetic Test that identifies the most effective diet and exercise program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, MA and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA).  For more information please visit www.ilgenetics.com.

Contacts:

Media:
Jon Siegal
Schwartz Communications, Inc.
(781) 684-0770
[email protected]

Investor Relations:
Eliot Lurier
Chief Financial Officer
Interleukin Genetics, Inc.
(781) 398-0700
[email protected]

SOURCE Interleukin Genetics, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED